Jeffrey W. Clark

Biomarkers of pembrolizumab efficacy in advanced anal squamous cell carcinoma: analysis of a phase II clinical trial and a cohort of long-term responders

Lestat R. Ali, W. Goessling, J. Meyerhardt, 2024, Journal for ImmunoTherapy of Cancer.

Patient-Reported Outcomes, Tumor Markers, and Survival Outcomes in Advanced GI Cancer

R. Nipp, A. Mojtahed, A. Parikh, 2023, JAMA network open.

O6-Methylguanine DNA Methyltransferase Deficiency and Response to Temozolomide-Based Therapy in Patients with Neuroendocrine Tumors

J. Meyerhardt, P. Enzinger, J. Hornick, 2009, Clinical Cancer Research.